Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Baxter
FDA Approves VANCOMYCIN HYDROCHLORIDE — Baxter Healthcare Corporation

# FDA Approves Baxter Healthcare's Vancomycin Hydrochloride for Intravitreal Injection Baxter Healthcare Corporation received FDA approval for Vancom...

Teva
FDA Approves BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA announced the approval of the generic version of Bisoprolol Fumarate and Hydrochlorothiazide (NDA020186), a broad-spectrum hy...

Hikma
FDA Approves LEUCOVORIN CALCIUM — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. secured the approval of a new generic version of LEUCOVORIN CALCIUM, an essential drug indicated for rescue following m...

Hikma
FDA Approves LEUCOVORIN CALCIUM — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. has announced the approval of its Abbreviated New Drug Application (ANDA) for leucovorin calcium oral, a therapeutic ag...

Apotex
FDA Approves PAXIL — Apotex Corp

Apotex Corp's launch of the generic version of Paxil (paroxetine hydrochloride) introduces increased competition into the depression and anxiety marke...

Rhodes
FDA Approves DILAUDID — Rhodes Pharmaceuticals LLC

Rhodes Pharmaceuticals LLC announced that the U.S. Food and Drug Administration has granted approval for the **DILAUDID** (Hydromorphone Hydrochloride...

RISING
FDA Approves Unknown Drug — RISING

Rising Pharma announced an FDA approval for its generic antibiotic combination submitted under ANDA #072838, a decision expected to intensify competit...

ANI
FDA Approves VALPROIC ACID — ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. announced FDA approval of its oral Valproic Acid generic (ANDA073178), a development that further diversifies the company's ...

Actavis
FDA Approves BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Actavis Pharma, Inc.

Actavis Pharma has confirmed the continued availability of the approved brand and generically equivalent Butalbital, Acetaminophen, Caffeine, and Code...

B.
FDA Approves HEPARIN SODIUM IN SODIUM CHLORIDE — B. Braun Medical Inc.

B. Braun Medical Inc. received FDA approval on July 20, 1992, for Heparin Sodium in Sodium Chloride marked under NDA019953, solidifying a long-standin...

Organon
FDA Approves PROSCAR — Organon LLC

# FDA Approves Organon's PROSCAR (Finasteride) for Oral Use Organon LLC received FDA approval for PROSCAR (finasteride), an oral medication that is e...

Mylan
FDA Approves METHOTREXATE — Mylan Pharmaceuticals Inc.

# FDA Approval Newswire Mylan Pharmaceuticals Inc. received FDA approval for its oral methotrexate sodium formulation (ANDA081235), expanding the com...

Actavis
FDA Approves MINOCYCLINE HYDROCHLORIDE — Actavis Pharma, Inc.

Actavis Pharma, Inc. has received approval for its generic version of minocycline hydrochloride (ANDA063181), a timely move that increases competition...

AIPING
FDA Approves Unknown Drug — AIPING PHARM INC

Aiping Pharm Inc secured FDA approval via this Abbreviated New Drug Application, a regulatory milestone that establishes the pathway for market distri...

PFIZER
FDA Approves Unknown Drug — PFIZER

The U.S. Food and Drug Administration has approved a new application for Pfizer, adding a strategic asset to the company's portfolio despite the absen...

Amgen,
FDA Approves NEUPOGEN — Amgen, Inc

Amgen, Inc.'s flagship product NEUPOGEN (filgrastim) received FDA approval (BLA103353) in 1991, pioneering the use of filgrastim to stimulate white bl...

KING
FDA Approves Unknown Drug — KING PHARMS LLC

KING PHARMS LLC has received FDA regulatory approval for NDA019901, establishing formal clearance for a new pharmaceutical entry. This development car...

Teva
FDA Approves METHOTREXATE — Teva Pharmaceuticals USA, Inc.

# FDA Approves Teva Pharmaceuticals' Generic Methotrexate Oral Formulation Teva Pharmaceuticals USA, Inc. received FDA approval for its generic metho...

ALVOGEN
FDA Approves Unknown Drug — ALVOGEN

ALVOGEN has received FDA approval for its Abbreviated New Drug Application (ANDA063067), reinforcing the company's competitive positioning in the gene...

Viatris
FDA Approves DIPENTUM — Viatris Specialty LLC

Viatris Specialty LLC has received FDA approval for DIPENTUM (olsalazine sodium) Oral Suspension, an updated formulation of the drug originally approv...